Cagrilintide-semaglutide plus basal insulin lowered A1C and weight in adults with type 2 diabetes
A Lancet phase 3a trial found cagrilintide-semaglutide added to basal insulin lowered A1C and weight...
Berobenatide VESPER Results: What Patients Should Know
Phase 2b VESPER data suggest berobenatide may lower weight and A1C, but it remains investigational...
B. Braun Dialysis Bloodline Recall: FDA Alert and Affected Lots
FDA warns about three lots of B. Braun Streamline dialysis bloodlines. Check the affected identifiers...
Awiqli Once-Weekly Insulin: US Approval Now Includes Children Aged 10 and Older
The FDA has expanded Awiqli approval to children aged 10+ with type 2 diabetes. Understand...
Automated Insulin Delivery and Advanced Kidney Disease: What People With Diabetes Should Know
A randomized trial found that automated insulin delivery improved time in range for adults with...
Afrezza Inhaled Insulin for Children: What Families Should Check
Patient-friendly Afrezza pediatric approval update covering age, mealtime insulin role, lung safety, hypoglycemia, DKA limits...
365 Ashwagandha Recall: Nationwide Salmonella Warning
Check the recalled 365 ashwagandha lot, discard instructions and Salmonella symptoms, plus separate supplement cautions...